NewsLepton announced today that it has filed a patent titled “Methods for Enhanced Genome Editing.”

January 22, 2026by admin

The patent covers a method for improving the efficiency of homology-directed repair (HDR)-based replacement of an endogenous DNA sequence at a target site in a cell using a donor DNA sequence.

by admin

previous
Lepton announced today that its manuscript introducing Castling, a novel therapeutic concept for rewiring pathological gene-expression networks enabled by its TRIPLE™ technology, has been submitted for peer review.
https://www.leptonpharma.com/wp-content/uploads/2021/04/logo_white_big-160x160.png

© 2023 Lepton Pharmaceuticals Inc.  All rights reserved
Design & Development by WCT

Our products

Our science

Terms of use